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Abstract
Background: Limited reliability data exist for evaluation of spinal edema changes on magnetic resonance imaging (MRI)
with short tau inversion recovery (STIR) sequences.
Purpose: To assess the inter-observer reliability for evaluation of STIR signal increase related to Modic changes (MCs)
on MRI of the lumbar spine.
Material and Methods: We prospectively included 120 patients imaged to confirm their eligibility for the AIM
(Antibiotics In Modic changes) trial. Three experienced radiologists independently evaluated MCs on T1-/T2-weighted
fast spin-echo images and subsequently MC-related STIR signal increases. Inter-observer reliability was analyzed at four
endplates (L4–S1) by calculating kappa values and means of differences with 95% limits of agreement.
Results: Overall agreement (mean Fleiss’ kappa for all endplates and observers) was very good for presence of STIR
signal increase (0.86), and moderate for its categorized height (0.51), anteroposterior extent (0.48), and volume (0.56).
For height of region with STIR signal increase measured in % points of vertebral body height, the largest mean of
differences was 6.9 and widest range for limits of agreement was 22.3 for all endplates combined. The corresponding
numbers were 11.2 34.5 for anteroposterior extent of the STIR signal increase measured in % points of anteropos-
terior endplate diameter and 0.9 7.6 for its maximum measured intensity on a % point scale (0%¼ normal vertebral
marrow intensity, 100%¼ cerebrospinal fluid intensity).
Conclusion: Inter-observer reliability was very good for the presence and intensity of MC-related STIR signal increases,
and moderate for their size.
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Introduction
Short tau inversion recovery (STIR) sequences are
widely used in magnetic resonance imaging (MRI) to
evaluate edematous changes in the skeleton, including
the spine. Despite widespread use, limited reliability
data exist for spinal evaluations with STIR or other
fluid-sensitive fat-suppressed series. Such data were
included in articles on spondylarthritis (1–5), fractures
(6), Modic changes (MCs) (7), hemangiomas (8), and
pedicle screw loosening (9). However, all but one (6) of
these reliability studies had only two observers, most
(1,3–5,7–9) had small patient samples (n¼ 25–41), only
one (8) included measurements (of signal intensities);
the spondylarthritis studies were limited to lesion
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detection (1–5). Reliability estimates differed widely in
these heterogeneous studies where radiologists and
non-radiologists interpreted various fat-suppressed
1.5-T or 3-T series. More comprehensive reliability
data are needed for radiologists’ lumbar spine evalua-
tions with STIR.
There has been increasing focus on MCs in recent
years. MCs are signal changes in the vertebral bone
marrow extending from the endplate and are classified
into types I (edema type), II (fatty type), and III
(sclerotic type) based on T1-weighted (T1W) and
T2-weighted (T2W) series (10–12). STIR series are sen-
sitive to edema and are highly relevant for evaluation
of MCs. The association between MCs and pain is
inconsistent (13–16), but edema type MCs might be
symptomatic (17–19). Mechanical, autoimmune, and
infectious explanations for MCs have been proposed
(20), and various treatments have been and are being
tested (21–34). Reliable evaluation of the STIR findings
is required to validate their relevance to symptoms and
treatment (35–37).
Clinicians and researchers evaluate MCs with a
combination of MRI series. The reliability is mostly
well described for evaluations with non-fat-suppressed
T1W/T2W sequences (38–43), but not for evaluations
with fat-suppressed, fluid-sensitive series (7). The pri-
mary aim of this study was to assess the inter-observer
reliability for evaluation of STIR signal increase related
to MCs on MRI of the lumbar spine. For comparison,
we also report the inter-observer reliability for the eval-
uation of these MCs on T1W/T2W fast spin-echo
images.
Material and Methods
This reliability study was based on a study-specific
MRI of a consecutive subsample (n¼ 120; 72 women,
48 men; age range¼ 25–64 years; mean age¼ 45 years)
with chronic low back pain considered for inclusion in
the AIM (Antibiotics In Modic changes) trial (32).
Inclusion required presence of type I and/or type II
MCs at the level of an MRI-confirmed lumbar disc
herniation within the preceding two years. All eligibil-
ity criteria are listed in the Appendix (Suppl. Table 1).
Patients preliminarily eligible for the trial based on
these criteria and findings on an existing clinical MRI
(n¼ 220) underwent the new study-specific MRI to
confirm or reject their eligibility. All participants
included in the study provided written informed con-
sent. The present report adheres to the guidelines for
reporting reliability and agreement studies (44).
Images
The 120 study-specific MRI examinations were per-
formed from 15 June 2015 to 2 September 2016 at
five centers in Norway, using identical protocols and
1.5-T scanners (Siemens Magnetom Avanto B19). The
present study was based on sagittal T1W and T2W fast
spin-echo images (¼T1/T2) and sagittal STIR images
(Table 1).
Evaluation
Three radiologists, all with >10 years of experience in
musculoskeletal MRI, independently evaluated the
images. The first observer to open the MRI examina-
tion saved a mark on the lowest lumbar disc level. All
observers reported this level as L5/S1. First, MCs were
rated on T1/T2, blinded to other sequences. Later the
observers rated STIR findings and decided whether any
increased STIR signal was related to an MC visible on
T1/T2. The observers were blinded to clinical outcome
but knew that patients were preliminarily eligible for
the trial. To align their understanding of procedures
and rating criteria, the observers rated and discussed
MCs and STIR findings in a pilot study (32 MRIs not
included in the main study).
On T1/T2, we defined MCs as signal changes in the
vertebral bone marrow extending from the endplate,
and based rating criteria for MC type and size on
prior work (10,11,38,45) (Table 2). Only T1/T2 findings
defined MC types I, II and III, not STIR findings. Not
recorded as MCs were: (i) changes separated from the
endplate; (ii) roundly shaped fatty changes abutting the
endplate with a smaller base than height (more likely
focal fatty marrow or hemangiomas); and (iii) changes
extending through the endplate (Schmorl’s hernias).
On STIR, we defined MC-related signal increase as
visible increase compared to normal vertebral bone
marrow, formed and located as an MC and/or located
in or abutting a region with MC on T1/T2 (and not
located in a likely hemangioma). MC-related STIR
signal increase was evaluated for presence, height, ante-
roposterior (AP) extent, volume, and maximum inten-
sity (Table 2). STIR signal decrease was not evaluated.
STIR signal intensity was measured in the region with
most intense MC-related STIR signal, in the cerebro-
spinal fluid (CSF) and in normal vertebral body
marrow (Table 2, Fig. 1). The measurements were
made in circular regions of interest available in our
PACS with size 25mm2 (used for most intense MC-
related STIR signal and CSF) and 44mm2 (used for
normal vertebral body marrow) (Fig. 1). Care was
taken to avoid surrounding structures, e.g. interverte-
bral discs, nerve roots, central vertebral vein. Intensity
of CSF varied between levels and was measured at the
2 Acta Radiologica Open
same disc level as the MC-related STIR signal. Maximum
intensity of the MC-related STIR signal (“Stir”) in %
points on a scale from normal vertebral body intensity
(“Body,” 0%) to CSF intensity (“CSF,” 100%) was cal-
culated as ((Stir – Body)/(CSF – Body)) 100.
Statistical analyses
For each endplate L4–S1, we calculated Fleiss’ kappa
for all observers and Cohen’s kappa for each observer
pair. Kappa was unweighted for dichotomous variables
and linearly weighted for ordinal variables. McNemar’s
test was applied to compare the prevalence of findings
between observers. We computed means of differences
between observers with 95% limits of agreement for
height and AP extent of findings in % points of verte-
bral body height and AP extent, and for STIR signal
intensity in % points on the scale from normal verte-
bral body intensity (0%) to CSF intensity (100%). We
used sample size weighted means and pooled limits of
agreement from all endplates to compute the mean dif-
ferences between the observers with 95% limits of
agreement for all endplates. The 95% limits of agree-
ments represent the limits within which 95% of the
differences are expected to occur. We used MedCalc
17.6 (MedCalc Software) to compute means, R 3.5 (R
Foundation for Statistical Computing) for kappa and
weighted means, and Matlab 9.5 (Mathworks) to
derive forest plots.
Only data from L4/L5 and L5/S1 were analyzed, due
to <10% prevalence of MCs at higher levels. Kappa is
usually not reported for findings with prevalence
<10%, as very low prevalence can lead to very low
kappa values despite very high actual agreement (46).
Kappa was interpreted as: k 0.20¼ poor; 0.21–
0.40¼ fair; 0.41–0.60¼moderate; 0.61–0.80¼ good; and
0.81–1.00¼ very good agreement beyond chance (47).
Sample size
Assuming a finding has a prevalence of 30%, 85
patients are needed to detect (b¼ 0.2, two-sided
a¼ 0.05) an unweighted pairwise kappa value of 0.70
as significantly larger than 0.40 (46). We used three
observers and 120 patients to further improve the
power and increase the size of subgroups. In general,
at least 50 individuals are recommended in reliability
studies (48).
Results
The observers reported MC-related STIR signal
increases regardless of MC type on T1/T2. There
were no missing data.
Categorical STIR variables
Overall agreement between the three radiologists
(mean Fleiss’ kappa) was very good for presence of
Table 1. MRI parameters for sagittal fast spin-echo T1W, T2W, and STIR images of the lumbosacral spine.
Parameter T1 T2 STIR
TR (ms) 575 3700 5530
TE (ms) 11 87 70
ETL 5 17 20
Acquisitions (n) 2 2 1
Concatenations (n) 2 1 1
Slices (n) 17 17 15
Matrix (frequency phase) 384 269 384 269 320 224
FOV (mm) 300 300 300 300 300 300
Slice thickness (mm) 4.0 4.0 4.0
Interslice gap (mm) 0.4 0.4 0.4
Voxel size (mm) 1.1 0.8 4.0 1.1 0.8 4.0 1.3 0.9 4.0
Receiver bandwidth (Hz/px) 161 161 182
Phase encoding direction Head to feet Head to feet Head to feet
Saturation pulses None Anterior, 30mm Anterior, 30mm
Acquisition time (min:s) 1:48 1:49 1:58






Phase oversampling (%) 70 70 70
TI (ms) 160
PAT mode Grappa Grappa None
MRI was performed on 1.5-T Magnetom Avanto scanners (Siemens) with B19 software using integrated spine array coil, but no surface coils.
ETL, echo train length; FOV, field of view; MRI, magnetic resonance imaging; PAT, parallel acquisition technique; STIR, short tau inversion recovery;
TE, echo time; TI, inversion time; TR, repetition time.
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MC-related STIR signal increase (0.86), and moderate
for its height (0.51), AP extent (0.48), and volume
(0.56) (Fig. 2). Kappa values were generally lower at
L5/S1 inferior to disc.
The prevalence of STIR signal increase differed
maximum 11.6% points between observers (observers
A vs. B reported prevalence of 58.3% vs. 46.7% at L5/
S1 inferior to disc, P< 0.001).
Mean pairwise Cohens’ kappa across all categorical
STIR variables and levels indicated slightly better
agreement between observers A and B (0.62) versus A
and C (0.52) and B and C (0.52). Further pairwise
STIR results are found in the Appendix (Suppl.
Fig. 1, Suppl. Table 2).
Numerical STIR variables
For height of the region with STIR signal increase in
% of vertebral body height, the largest mean of differ-
ences between observers was 6.9% points and the
widest limits of agreement were 22.3% points,
based on data from all levels (Fig. 3). For AP extent
of the increased STIR signal in % of AP endplate
diameter, the corresponding numbers were 11.2%
Table 2. Criteria for evaluating MCs and related STIR signal increases.
Variables Description, criteria
MC characteristics evaluated on sagittal T1W and T2W images, blinded to STIR images
Type Primary (most extensive) and secondary MC types rated as type I (hypo-intense on T1, hyper-
intense on T2), type II (hyperintense on T1, iso- or hyperintense on T2), or type III (hypointense
on T1 and T2). Borderline type I vs. type II MCs (near iso-intense on T1) are rated as type II
(i.e. type I requires a clearly hypo-intense region on T1)
Height Largest height of MC measured in mm and rated as <10%, <25%, 25–50%, or >50% of vertebral
body height in mm. Both heights are measured along the same line on the same image, excluding
the thin low-intensity cortical borders between the bone marrow and the discs.* The <10%
category also includes MCs with diameter 5mm
AP extent Largest AP extent of MC measured in mm and rated as <25%, 25–50%, or >50% of the mid-sagittal
AP diameter of the endplate measured in mm
Volume MC volume subjectively estimated to <10%, <25%, 25–50%, or>50% of total vertebral body
marrow volume, taking into account the affected area on all images
STIR signal increase (MC-related), evaluated with T1W/TW2 images available
Presence Presence of visible STIR signal increase compared to normal vertebral bone marrow, in relation to
MCs seen on T1W/T2W images – or located and shaped as MCs. Rated as no, inside MC, in- and
outside MC, or outside MC
Height Largest height of the region with high STIR signal measured in mm and rated as <10%, <25%,
25–50%, or >50% of vertebral body height in mm. STIR signal height and vertebral body height
are both measured along the same line on the same image, excluding the low-intensity cortical
borders between the bone marrow and the discs*
AP extent Largest AP extent of the high STIR signal measured in mm and rated as <25%, 25–50%, or >50% of
the mid-sagittal AP diameter of the endplate measured in mm
Volume Volume of the high STIR signal subjectively rated as <10%, <25%, 25–50%, or >50% of total
vertebral body volume, taking into account the affected area on all images
Intensity Maximum intensity of the high STIR signal, measured in a 25 mm2 ROI
CSF intensity STIR signal intensity in the CSF at the level of the vertebral unit with high STIR signal, measured in a
25 mm2 ROI on the mid-sagittal image, or the next image left or right, avoiding non-CSF
structures. If possible, the CSF signal is measured behind the lower half of the cranial vertebra of
the vertebral unit (e.g. behind L4 in the L4/L5 unit, if the MC-related STIR signal increase is
superior and/or inferior to the L4/L5 disc)
Vertebral body intensity STIR signal intensity in normal (on STIR, T1 and T2) vertebral body marrow, measured in a 44 mm2
ROI near the endplate in the central AP third of the opposite normal part (caudal or cranial) of
the vertebra with high STIR signal. If this part is not normal, and always when the high STIR signal
is in S1, the nearest vertebra above is used for measurement, its caudal part if possible, otherwise
its cranial part. The measurement is first considered in the midsagittal image and the next image
left or right, before a new location may be considered. The central vertebral vein is not included
in the ROI
*In S1 laterally, if the image intended for measuring vertebral body height does not show the S1/S2 interface, the next more medial image is used for
this measurement.
AP, anteroposterior; CSF, cerebrospinal fluid; MC, Modic change; ROI, region of interest; STIR, short tau inversion recovery.
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points 34.5% points. For maximum intensity of the
STIR signal in % on the scale from normal vertebral
body intensity (0%) to CSF intensity (100%), the larg-
est mean of differences and widest limits of agreement
were 0.9% and 7.6% points, based on data from all
levels. Results for individual levels are provided in the
Appendix (Suppl. Fig. 2).
Reported % points were in the range of 8–100 (mean-
¼ 43) for height, 7–100 (mean¼ 74) for AP extent, and
6–78 (mean¼ 32) for intensity of STIR signal increases.
MC evaluation on T1/T2
On T1/T2, agreement (mean Fleiss’ kappa) was very
good for presence of MCs (0.88) and for presence of
Fig. 1. (a–c) STIR signal increases related to MCs. A 48-year old woman with type II MCs and MC-related STIR signal increases
superior and inferior to the L5/S1 disc. The figure shows measurements of (a) height, (b) AP extent, and (c) maximum intensity of the
STIR signal with vertebral body and CSF intensities for reference. (c) The circular regions of interest used for measurements are
visible with their sizes and gray-scale values, from left to right: maximum intensity (area¼ 24.9mm2, average¼ 131.1 GY), vertebral
body intensity (area¼ 44.2mm2, average¼ 45.05 GY), and CSF intensity (area¼ 24.9mm2, average¼ 360.8 GY). Corresponding
T1W/T2W fast spin-echo images show type II MCs. Note the diffuse outline of the STIR signal. Note also the thin hyperintense zone
on STIR near normal endplates (arrow), which may be mistaken for an AP continuation of an MC-related STIR signal increase at
endplates with such increase. AP, anteroposterior; CSF, cerebrospinal fluid; MC, Modic change; STIR, short tau inversion recovery.
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primary or secondary type I MCs (0.81) (Fig. 4). Mean
kappa was 0.64 for height, 0.56 for AP extent, and 0.69
for volume of MCs on T1/T2. These values were 0.08–
0.13 higher than the corresponding kappa values for
dimensions of MC-related STIR signal increases.
The largest difference between observers in preva-
lence of MCs on T1/T2 was 6.7% points (observers
A vs. B reported prevalence 79.2% vs. 72.5% at
L5/S1 inferior to disc, P¼ 0.021).
Mean pairwise Cohens’ kappa across all categorical
T1/T2 variables and levels indicated similar agreement
between observers A and B (0.73), A and C (0.71), and
B and C (0.73).
The largest mean of differences (and widest limits of
agreement) on T1/T2 were for MC height 0.7 (17.4)
% points and for AP extent of MCs 2.6 (28.8) %
points (Fig. 5). These values were smaller than the
corresponding values on STIR. On T1/T2, reported
% points were in the range of 5–91 (mean¼ 39) for
height and 8–100 (mean¼ 78) for AP extent.
Further T1/T2 results are detailed in the Appendix
(Suppl. Figs. 3 and 4, Suppl. Table 3).
Discussion
To our knowledge, this was the first comprehensive
study of the inter-observer reliability for evaluations
of STIR signal increases in the vertebral bone
marrow. Three radiologists evaluated MC-related
high-intensity regions on STIR in 120 patients.
Overall inter-observer agreement was very good for
the presence of STIR signal increase and moderate
for its height, AP extent, and volume. In general, %
measured height of the STIR signal differed less
Fig. 2. Categorical STIR variables: forest plot for kappa values with 95% CIs. The figure shows Fleiss’ kappa values with 95% CIs for all
observers for variables describing MC-related STIR signal increases superior (sup) and inferior (inf) to the L4/L5 and L5/S1 discs.
These variables were presence (yes/no), height (four categories), AP extent (three categories), and volume (four categories) of region
with high STIR signal. Mean kappa value for agreement between all raters across all four levels L4–S1 is marked with a bold vertical
line. This line and circles representing kappa values are green for kappa values>0.50 (the midpoint of the moderate agreement
category) and otherwise red. AP, anteroposterior; CI, confidence interval; MC, Modic change; STIR, short tau inversion recovery.
Fig. 3. Numerical STIR variables: forest plot for means of differences and limits of agreement. The figure shows mean of differences
with 95% limits of agreement in observer pairs A/B, A/C, and B/C for three numerical variables describing STIR signal increases
related to MCs. Each variable was evaluated at four endplates (superior and inferior to the L4/L5 and L5/S1 discs). Means for all
endplates are displayed. Values are % points. Hperc denotes height of region with high STIR signal in % of the height of the vertebral
body marrow; APperc denotes AP extent of the high STIR signal in % of the mid-sagittal AP diameter of the endplate; intPerc denotes
maximum intensity of the STIR signal in % on a scale from normal vertebral body marrow intensity (0%) to CSF intensity (100%).
AP, anteroposterior; CSF, cerebrospinal fluid; MC, Modic change; STIR, short tau inversion recovery.
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between observers than its % measured AP extent. For
its maximum intensity (on a scale of 0–100%), mean of
differences was <1% points and limits of agreement
within 7.6% points.
Further, we have found only one previous study
(on 25 patients) of the reliability for MC evaluations
on any fat-suppressed fluid-sensitive series (7). In that
study, kappa for inter-observer agreement was 0.74 for
presence and 0.80 for categorized height of MC-related
signal increase. Our corresponding kappa values were
0.86 and 0.51. In patients with possible vertebral frac-
tures (6), kappa for inter-observer agreement on cate-
gorized volume of vertebral bone edema on STIR
was 0.58; our value was 0.56. It was not reported in
these previous studies whether kappa was weighted or
categories were combined, so it is not clear whether
their kappa values are comparable to ours. In line
with our results for intensity measurements, inter-
observer agreement was excellent for measurements
of signal intensities in vertebral hemangiomas on
STIR/fat-saturated T2 images (intra-class correlations
of 0.97–0.99) (8).
The very good agreement on presence of STIR
signal increases in our study is reassuring for clinical
work and research. However, the moderate agreement
on the extent of the high STIR signal is not optimal.
Moderate inter-observer agreement is common in spine
imaging (36,41,49,50), but it implies lowered accuracy
when associations with clinical factors are sought (37).
More reliable conclusive MRI findings can be based on
different observers’ separate evaluations followed by
their joint conclusion (51). Furthermore, in order to
improve agreement between observers, reasons for dis-
agreement should be identified and addressed.
Reasons for disagreement on extent of STIR signal
increases may be diffuse outline/gradual lessening of
the signals and inhomogeneous bone marrow signal,
especially in S1 (where agreement was slightly poorer)
(Fig. 2). The AP extent of the MC-related STIR signal
often tapers gradually and may blend into a normal
Fig. 4. Categorical MC variables on T1/T2: forest plot for kappa values with 95% CIs. The figure shows Fleiss’ kappa values with 95%
CIs for all observers for variables describing MCs superior (sup) and inferior (inf) to the L4/L5 and L5/S1 discs on T1W/T2W fast spin-
echo images. These variables were presence of any type of MCs (yes/no), presence of primary or secondary type I MCs (yes/no),
height (four categories), AP extent (three categories), and volume (four categories) of the MCs. Mean kappa value for agreement
between all raters across all four levels L4–S1 is marked with a bold vertical line. This line and circles representing kappa values are
green for kappa values>0.50 (the midpoint of the moderate agreement category) and otherwise red. AP, anteroposterior;
CI, confidence interval; MC, Modic change; STIR, short tau inversion recovery.
Fig. 5. Numerical MC variables on T1/T2: forest plot for means of differences and limits of agreement. The figure shows mean
of differences with 95% limits of agreement in observer pairs A/B, A/C, and B/C for two numerical variables describing MCs on
T1W/T2W fast spin-echo images. Each variable was evaluated at four endplates (superior and inferior to the L4/L5 and L5/S1 discs).
Means for all endplates are displayed. Values are % points. Hperc denotes height of the MC in % of the height of the vertebral body
marrow; APperc means AP extent of the MC in % of the mid-sagittal AP diameter of the endplate. AP, anteroposterior; MC, Modic
change.
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thin hyperintense zone beneath the bony endplate
(Fig. 1). This can partly explain larger disagreement
for AP extent than for height. The generally larger
AP extent than height of the STIR signal is not a
likely explanation, as differences in % measured AP
extent of the signal were similar for small and large
extents (data not shown). On T1/T2, better agreement
was achieved for MC extent both in our study and
between other experienced observers (36,40,49,50).
Therefore, disagreement on extent of MC-related
STIR signal increase is probably due to genuine diffi-
culties in interpretation.
Our study also added new information regarding the
detection of any area with type I MCs on T1/T2.
Previous studies have focused on primary MC types
(38–41). We found very good agreement on presence
of any (primary or secondary) type I MCs. This may be
partly because we rated borderline type I versus type II
MCs with near isointense T1 signal (no clear edema) as
type II. MCs that are isointense on T1 (and hyperin-
tense on T2) fall outside the original definition of MC
types, and it is unclear how they were classified in other
studies.
The strengths of this study include the use of three
observers (all experienced radiologists), a pilot study, a
large sample, standardized MRI protocols and rating
criteria, and inclusion of measurements. Multiple
observers improved the power and the generalizability
of results, and including more patients rather than
more than three observers is an effective strategy for
maximizing power (46). The data on reliability for
T1/T2 evaluations of MCs supported the credibility
of our STIR results. We also standardized MC-
related STIR signal intensities against normal bone
marrow and CSF at the same or a close level, since
intensity values varied both between and within
patients and depended on craniocaudal and AP
localization.
There are also limitations to the study. It was
restricted to patients with previously reported MCs
and disc herniation. We would however expect similar
reliability for STIR evaluations in other patients with
low back pain. Intra-observer reliability was not exam-
ined; it is often better than the inter-observer reliability
(41,43,49,50). A single type of 1.5-T MRI scanner was
used, and the results may not be transferrable to images
with a different quality or to scanners with a different
field strength. Lesion volume was not measured; it was
categorized by taking into account (summing up) the
visually estimated affected area on all images.
Although precise measurements on all images is less
feasible, reliability data also for measured volume
would have been useful. Finally, all observers
had>10 years of experience in musculoskeletal MRI
and the reliability for less specialized or less experi-
enced radiologists is still unknown.
We propose the following implications of our
results. First, radiologists can evaluate STIR signal
increases in the lumbar spine based on criteria used
in this study. Second, clinicians and radiologists can
expect more reliable evaluation of the height versus
the AP extent of a region with MC-related STIR
signal increase. Third, when relevant, radiologists can
grade the volume of STIR signal increases with reason-
able inter-observer reliability, without performing very
time-consuming measurements. Fourth, one should
still attempt to improve the reliability for size evalua-
tions of STIR signal increases in research, e.g. by joint
pre-training, semi-automated lesion contouring (37),
continuous volume measurements, and basing conclu-
sive findings on multiple observers’ evaluations (51).
Fifth, maximum STIR signal intensity relative to
normal bone marrow and CSF is an attractive variable
in further research, due to its excellent inter-observer
reliability. Finally, radiologists can use criteria from
this study to improve the evaluation of type I MCs
on T1W/T2W fast spin-echo images.
In conclusion, the agreement between experienced
radiologists was very good regarding the presence of
MC-related STIR signal increase and its maximum
intensity, and moderate for its extent and volume.
These results provide a basis for validating the rele-
vance of such STIR signal increases for symptoms
and treatment results.
Acknowledgments
The authors thank their collaborators in the AIM study
group for their contributions.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) received the following financial support for the
research, authorship, and/or publication of this article: This
work was supported by the South East Norway Regional
Health Authority (grant no. 2015-090) and the Western
Norway Regional Health Authority (grant nos. HV 911891
and HV 911938). They had no role in study design; collection,
analysis, and interpretation of data; writing of the report; or
the decision to submit the report for publication.
The Regional Committees for Medical Research Ethics in
Norway approved this study and the trial it was based on
(REC South East, approval no. 2014/158). The trial is regis-
tered at ClinicalTrials.gov (identifier NCT02323412).
8 Acta Radiologica Open
ORCID iD
Per Martin Kristoffersen https://orcid.org/0000-0001-
6471-8861
Supplemental Material
Supplemental material for this article is available online.
References
1. Maksymowych WP, Crowther SM, Dhillon SS, et al.
Systematic assessment of inflammation by magnetic res-
onance imaging in the posterior elements of the spine in
ankylosing spondylitis. Arthritis Care Res (Hoboken)
2010;62:4–10.
2. Agten CA, Zubler V, Rosskopf AB, et al. Enthesitis of
lumbar spinal ligaments in clinically suspected spondy-
loarthritis: value of gadolinium-enhanced MR images in
comparison to STIR. Skeletal Radiol 2016;45:187–195.
3. Baraliakos X, Hermann KG, Landewe R, et al.
Assessment of acute spinal inflammation in patients
with ankylosing spondylitis by magnetic resonance imag-
ing: a comparison between contrast enhanced T1 and
short tau inversion recovery (STIR) sequences. Ann
Rheum Dis 2005;64:1141–1144.
4. Song IH, Hermann KG, Haibel H, et al. Inflammatory
and fatty lesions in the spine and sacroiliac joints on
whole-body MRI in early axial spondyloarthritis–
3-Year data of the ESTHER trial. Semin Arthritis
Rheum 2016;45:404–410.
5. Lecouvet FE, Vander Maren N, Collette L, et al. Whole
body MRI in spondyloarthritis (SpA): Preliminary
results suggest that DWI outperforms STIR for lesion
detection. Eur Radiol 2018;28:4163–4173.
6. Diekhoff T, Engelhard N, Fuchs M, et al. Single-source
dual-energy computed tomography for the assessment of
bone marrow oedema in vertebral compression fractures:
a prospective diagnostic accuracy study. Eur Radiol
2019;29:31–39.
7. Finkenstaedt T, Del Grande F, Bolog N, et al. Modic
type 1 changes: detection performance of fat-suppressed
fluid-sensitive MRI sequences. RoFo 2017;190:152–160.
8. Nabavizadeh SA, Mamourian A, Schmitt JE, et al.
Utility of fat-suppressed sequences in differentiation of
aggressive vs typical asymptomatic haemangioma of the
spine. Br J Radiol 2016;89:20150557.
9. Spirig JM, Sutter R, Gotschi T, et al. Value of standard
radiographs, computed tomography, and magnetic reso-
nance imaging of the lumbar spine in detection of intra-
operatively confirmed pedicle screw loosening-a
prospective clinical trial. Spine J 2019;19:461–468.
10. Modic MT, Ross JS, Masaryk TJ. Imaging of degenera-
tive disease of the cervical spine. Clin Orthop
1989;239:109–120.
11. Modic MT, Steinberg PM, Ross JS, et al.
Degenerative disk disease: assessment of changes in ver-
tebral body marrow with MR imaging. Radiology
1988;166:193–199.
12. Modic MT, Ross JS. Lumbar degenerative disk disease.
Radiology 2007;245:43–61.
13. Brinjikji W, Diehn FE, Jarvik JG, et al. MRI findings of
disc degeneration are more prevalent in adults with low
back pain than in asymptomatic controls: a systematic
review and meta-analysis. AJNR Am J Neuroradiol
2015;36:2394–2399.
14. Jensen TS, Karppinen J, Sorensen JS, et al.
Vertebral endplate signal changes (Modic change): a
systematic literature review of prevalence and association
with non-specific low back pain. Eur Spine J
2008;17:1407–1422.
15. Zhang YH, Zhao CQ, Jiang LS, et al. Modic changes: a
systematic review of the literature. Eur Spine J
2008;17:1289–1299.
16. Herlin C, Kjaer P, Espeland A, et al. Modic changes-
Their associations with low back pain and activity limi-
tation: A systematic literature review and meta-analysis.
PLoS One 2018;13:e0200677.
17. Hanimoglu H, Cevik S, Yilmaz H, et al. Effects of Modic
type 1 changes in the vertebrae on low back pain. World
Neurosurg 2019;121:e426–e432.
18. Splendiani A, Bruno F, Marsecano C, et al. Modic I
changes size increase from supine to standing MRI cor-
relates with increase in pain intensity in standing posi-
tion: uncovering the “biomechanical stress” and “active
discopathy” theories in low back pain. Eur Spine J
2019;28:983–992.
19. Maatta JH, Karppinen J, Paananen M, et al. Refined
phenotyping of Modic changes: imaging biomarkers of
prolonged severe low back pain and disability. Medicine
2016;95:e3495.
20. Dudli S, Fields AJ, Samartzis D, et al. Pathobiology of
Modic changes. Eur Spine J 2016;25:3723–3734.
21. Beaudreuil J, Dieude P, Poiraudeau S, et al. Disabling
chronic low back pain with Modic type 1 MRI signal:
acute reduction in pain with intradiscal corticotherapy.
Ann Phys Rehabil Med 2012;55:139–147.
22. Buttermann GR. The effect of spinal steroid injections
for degenerative disc disease. Spine J 2004;4:495–505.
23. Mefford J, Sairyo K, Sakai T, et al. Modic type I changes
of the lumbar spine in golfers. Skeletal Radiol
2011;40:467–473.
24. Cao P, Jiang L, Zhuang C, et al. Intradiscal injection
therapy for degenerative chronic discogenic low back
pain with end plate Modic changes. Spine J
2011;11:100–106.
25. Albert HB, Sorensen JS, Christensen BS, et al. Antibiotic
treatment in patients with chronic low back pain and
vertebral bone edema (Modic type 1 changes): a
double-blind randomized clinical controlled trial of effi-
cacy. Eur Spine J 2013;22:697–707.
26. Cai G, Laslett LL, Aitken D, et al. Effect of zoledronic
acid and denosumab in patients with low back pain and
Modic change: a proof-of-principle trial. J Bone Miner
Res 2018;33:773–782.
27. Fayad F, Lefevre-Colau MM, Rannou F, et al. Relation
of inflammatory modic changes to intradiscal steroid
Kristoffersen et al. 9
injection outcome in chronic low back pain. Eur Spine J
2007;16:925–931.
28. Koivisto K, Jarvinen J, Karppinen J, et al. The effect
of zoledronic acid on type and volume of Modic
changes among patients with low back pain. BMC
Musculoskelet Disord 2017;18:274.
29. Koivisto K, Kyllonen E, Haapea M, et al. Efficacy of
zoledronic acid for chronic low back pain associated
with Modic changes in magnetic resonance imaging.
BMC Musculoskelet Disord 2014;15:64.
30. Al-Falahi MA, Salal MH, Abdul-Wahab DM. Antibiotic
Treatment in Patients with Chronic Low Back Pain and
Vertebral Bone Edema (Modic Type I Changes): A
Randomized Clinical Controlled Trial of Efficacy. Iraqi
Postgraduate Medical Journal 2014;13:390–398.
31. Palazzo C, Ferrari M, Lefevre-Colau M-M, et al. Lack of
effectiveness of antibiotics in chronic low back pain with
Modic 1 changes. Joint Bone Spine 2017;84:507–508.
32. Storheim K, Espeland A, Grovle L, et al. Antibiotic
treatment In patients with chronic low back pain and
Modic changes (the AIM study): study protocol for a
randomised controlled trial. Trials 2017;18:596.
33. Wilkens P, Storheim K, Scheel I, et al. No effect of
6-month intake of glucosamine sulfate on Modic changes
or high intensity zones in the lumbar spine: sub-group
analysis of a randomized controlled trial. J Negat
Results Biomed 2012;11:13.
34. Braten LCH, Rolfsen MP, Espeland A, et al. Efficacy of
antibiotic treatment in patients with chronic low back
pain and Modic changes (the AIM study): double
blind, randomised, placebo controlled, multicentre trial.
BMJ 2019;367:l5654.
35. Feinstein AR. An additional basic science for clinical
medicine: IV. The development of clinimetrics. Ann
Intern Med 1983;99:843–848.
36. Jarvik JG, Deyo RA. Moderate versus mediocre: the reli-
ability of spine MR data interpretations. Radiology
2009;250:15–17.
37. Fields AJ, Battie MC, Herzog RJ, et al. Measuring and
reporting of vertebral endplate bone marrow lesions as
seen on MRI (Modic changes): recommendations from
the ISSLS Degenerative Spinal Phenotypes Group. Eur
Spine J 2019;28:2266–2274
38. Jensen TS, Sorensen JS, Kjaer P. Intra- and interobserver
reproducibility of vertebral endplate signal (modic)
changes in the lumbar spine: the Nordic Modic
Consensus Group classification. Acta Radiol
2007;48:748–754.
39. Jones A, Clarke A, Freeman BJ, et al. The Modic classi-
fication: inter- and intraobserver error in clinical practice.
Spine 2005;30:1867–1869.
40. Peterson CK, Gatterman B, Carter JC, et al. Inter- and
intraexaminer reliability in identifying and classifying
degenerative marrow (Modic) changes on lumbar spine
magnetic resonance scans. J Manipulative Physiol Ther
2007;30:85–90.
41. Arana E, Royuela A, Kovacs FM, et al. Lumbar spine:
agreement in the interpretation of 1.5-T MR images by
using the Nordic Modic Consensus Group classification
form. Radiology 2010;254:809–817.
42. Tibiletti M, Ciavarro C, Bari V, et al. Semi-quantitative
evaluation of signal intensity and contrast-enhancement
in Modic changes. Eur Radiol Exp 2017;1:5.
43. Wang Y, Videman T, Niemelainen R, et al. Quantitative
measures of modic changes in lumbar spine magnetic res-
onance imaging: intra- and inter-rater reliability. Spine
2011;36:1236–1243.
44. Kottner J, Audige L, Brorson S, et al. Guidelines for
Reporting Reliability and Agreement Studies (GRRAS)
were proposed. J Clin Epidemiol 2011;64:96–106.
45. Fardon DF, Williams AL, Dohring EJ, et al. Lumbar
disc nomenclature: version 2.0: Recommendations of
the combined task forces of the North American Spine
Society, the American Society of Spine Radiology and
the American Society of Neuroradiology. Spine J
2014;14:2525–2545.
46. Sim J, Wright CC. The kappa statistic in reliability stud-
ies: use, interpretation, and sample size requirements.
Phys Ther 2005;85:257–268.
47. Landis JR, Koch GG. The measurement of observer
agreement for categorical data. Biometrics
1977;33:159–174.
48. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria
were proposed for measurement properties of health
status questionnaires. J Clin Epidemiol 2007;60:34–42.
49. Berg L, Neckelmann G, Gjertsen O, et al. Reliability of
MRI findings in candidates for lumbar disc prosthesis.
Neuroradiology 2012;54:699–707.
50. Carrino JA, Lurie JD, Tosteson AN, et al. Lumbar spine:
reliability of MR imaging findings. Radiology
2009;250:161–170.
51. Espeland A, Vetti N, Krakenes J. Are two readers more
reliable than one? A study of upper neck ligament scoring
on magnetic resonance images. BMC Med Imaging
2013;13:4.
10 Acta Radiologica Open
